Ferric pyrophosphate citrate (Triferic™) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients

Administration of ferric pyrophosphate citrate (FPC, Triferic™) via hemodialysate may allow replacement of ongoing uremic and hemodialysis-related iron losses. FPC donates iron directly to transferrin, bypassing the reticuloendothelial system and avoiding iron sequestration. Two identical Phase 3, r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2015-12, Vol.30 (12), p.2019-2026
Hauptverfasser:	Fishbane, Steven N, Singh, Ajay K, Cournoyer, Serge H, Jindal, Kailash K, Fanti, Paolo, Guss, Carrie D, Lin, Vivian H, Pratt, Raymond D, Gupta, Ajay
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravenous Anemia, Iron-Deficiency - prevention & control CLINICAL SCIENCE Dialysis Solutions - therapeutic use Dietary Supplements Diphosphates - therapeutic use Female Ferric Compounds - therapeutic use Hematinics - therapeutic use Hemoglobins - metabolism Humans Iron - metabolism Iron - therapeutic use Male Middle Aged Prospective Studies Renal Dialysis Single-Blind Method Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!